Spruce Street Capital »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Spruce Street Capital

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Spruce Street Capital from 13F filings

Historical chart of Spruce Street Capital investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Spruce Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Spruce Street Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $59M 918k 63.95

More positions owned by Spruce Street Capital

Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Relay Therapeutics (RLAY)
Lb Pharmaceuticals Com Shs (LBRX)
Relmada Therapeutics (RLMD)
Alto Neuroscience Com Shs (ANRO)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Savara (SVRA)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Enanta Pharmaceuticals (ENTA)
Perspective Therapeutics Com New (CATX)
Inflarx Nv (IFRX)
Surrozen Com New (SRZN)
Alumis (ALMS)

View all positions for Spruce Street Capital

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

FMR
Rubric Capital Management
Baker Bros. Advisors
Tang Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
Acadian Asset Management
Caption Management
Morgan Stanley
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Spruce Street Capital
Dimensional Fund Advisors
Bank of America Corporation
Qube Research & Technologies

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A